NXgenPort today announced that it has entered into a license agreement with Mayo Clinic to develop and test an implantable chemo-port catheter. NXgenPort's technology has chemo-port efficacy with sensor technology to measure and remotely monitor the early onset of complications by reporting and tracking patient response during … [Read more...] about NXgenPort, Mayo Clinic ink license agreement over chemo-port catheter for home monitoring